Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bast

Showing results (211-220 of 293) with videos related to

Pageof 30
Sort By:
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|May 17, 2001
NF-kappaB activation in sarcoidosisM Drent, R van den Berg, G R Haenen, et al.
International Journal of Pharmaceutics|January 4, 2001
Stability of monoHER in an aqueous formulation for i.v. administrationM A Abou El Hassan, D J Touw, A J Wilhelm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Frederine, a new and promising protector against doxorubicin-induced cardiotoxicityF A van Acker, E Boven, K Kramer, et al.
Free Radical Research Communications|January 1, 1987
Red blood cell anti-oxidant parameters in healthy elderly subjects versus silicosis patientsP J Borm, A Bast, E F Wouters, et al.
Research Communications in Chemical Pathology and Pharmacology|January 1, 1985
The involvement of an oxidative mechanism in the adriamycin induced toxicity in neonatal rat heart cell culturesR H Julicher, A van der Laarse, L Sterrenberg, et al.
Anticancer Research|February 24, 2001
In vitro screening of antitumour agents for cardiotoxicity by means of isolated mouse left atriaF A van Acker, S A van Acker, G R Haenen, et al.
Journal of Transplantation|June 1, 2012
The Effect of Statins and Other Cardiovascular Medication on Ischemia-Reperfusion Damage in a Human DIEP Flap Model: Theoretical and Epidemiological ConsiderationsM G W van den Heuvel, A Bast, A W Ambergen, et al.
Journal of Molecular and Cellular Cardiology|September 1, 1994
Comparison of different iron chelators as protective agents against acute doxorubicin-induced cardiotoxicityE E Voest, S A van Acker, W J van der Vijgh, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Modulation of the in vitro cardiotoxicity of doxorubicin by flavonoidsB C Hüsken, J de Jong, B Beekman, et al.
Environmental Toxicology and Pharmacology|July 26, 2011
The role of prostanoids in ozone-induced changes in airway responsiveness: receptor activation-specific prostanoid releaseH J van Hoof, F J Zijlstra, H P Voss, et al.
Pageof 30

Showing results (211-220 of 293) with videos related to

Sort By:
Pageof 30
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|May 17, 2001
NF-kappaB activation in sarcoidosisM Drent, R van den Berg, G R Haenen, et al.
International Journal of Pharmaceutics|January 4, 2001
Stability of monoHER in an aqueous formulation for i.v. administrationM A Abou El Hassan, D J Touw, A J Wilhelm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Frederine, a new and promising protector against doxorubicin-induced cardiotoxicityF A van Acker, E Boven, K Kramer, et al.
Free Radical Research Communications|January 1, 1987
Red blood cell anti-oxidant parameters in healthy elderly subjects versus silicosis patientsP J Borm, A Bast, E F Wouters, et al.
Research Communications in Chemical Pathology and Pharmacology|January 1, 1985
The involvement of an oxidative mechanism in the adriamycin induced toxicity in neonatal rat heart cell culturesR H Julicher, A van der Laarse, L Sterrenberg, et al.
Anticancer Research|February 24, 2001
In vitro screening of antitumour agents for cardiotoxicity by means of isolated mouse left atriaF A van Acker, S A van Acker, G R Haenen, et al.
Journal of Transplantation|June 1, 2012
The Effect of Statins and Other Cardiovascular Medication on Ischemia-Reperfusion Damage in a Human DIEP Flap Model: Theoretical and Epidemiological ConsiderationsM G W van den Heuvel, A Bast, A W Ambergen, et al.
Journal of Molecular and Cellular Cardiology|September 1, 1994
Comparison of different iron chelators as protective agents against acute doxorubicin-induced cardiotoxicityE E Voest, S A van Acker, W J van der Vijgh, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Modulation of the in vitro cardiotoxicity of doxorubicin by flavonoidsB C Hüsken, J de Jong, B Beekman, et al.
Environmental Toxicology and Pharmacology|July 26, 2011
The role of prostanoids in ozone-induced changes in airway responsiveness: receptor activation-specific prostanoid releaseH J van Hoof, F J Zijlstra, H P Voss, et al.
Pageof 30